| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA630397 | A | Mouse plasma levels are obtained 24 hr after oral administration of 100 mg/kg of compound. | Mus musculus | 8 | organism-based format | Scientific Literature | ||
| 2. | ALA630398 | A | Mouse plasma levels are obtained 6 hr after oral administration of 100 mg/kg of compound. | Mus musculus | 9 | organism-based format | Scientific Literature | ||
| 3. | ALA678320 | B | FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro. | 33 | single protein format | Scientific Literature | |||
| 4. | ALA690705 | F | Inhibition of FGF-stimulated HUVEC cell proliferation | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 5. | ALA690866 | F | Inhibition of VEGFstimulated HUVEC cell proliferation | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 6. | ALA690867 | F | Inhibition of unstimulated HUVEC cell proliferation | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 7. | ALA811931 | B | In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP. | 35 | single protein format | Scientific Literature | |||
| 8. | ALA812620 | B | Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro. | 33 | single protein format | Scientific Literature | |||
| 9. | ALA852072 | B | Ratio of IC50 of FGFR-1 (FTK) to VEGFR-1 (Flt). | 28 | assay format | Scientific Literature | |||
| 10. | ALA852073 | B | Ratio of IC50 of FGFR-1 (FTK) to VEGFR-2 (KDR). | 29 | protein format | Scientific Literature | |||
| 11. | ALA3301364 | P | ASTRAZENECA: Solubility in pH7.4 buffer using solid starting material using the method described in J. Assoc. Lab. Autom. 2011, 16, 276-284. Experimental range 0.10 to 1500 uM | 1,763 | small-molecule physicochemical format | AstraZeneca Deposited Data |
The page will load shortly, Thanks for your patience!